» Articles » PMID: 25132266

MicroRNA Regulons in Tumor Microenvironment

Overview
Journal Oncogene
Date 2014 Aug 19
PMID 25132266
Citations 103
Authors
Affiliations
Soon will be listed here.
Abstract

Cancer initiation and progression are defined by the behavior of cancer cells per se and the development of tumor tissues, both of which are modulated by crosstalk between cancer cells and the surrounding microenvironment. Advances in cancer research have highlighted the significance of constant evolution of the tumor microenvironment, leading to tumor formation, metastasis and refractoriness to therapy. MicroRNAs (miRNAs) are small non-coding RNAs that function as major players of posttranscriptional gene regulation in diverse biological processes. They function as both tumor suppressors and promoters in many aspects of the autonomous behavior of cancer cells. Theoretically, dysfunction in the gene regulatory networks of cancer cells is one of the major driving forces for alterations of ostensibly normal surrounding cells. In this context, the core targets of miRNAs, termed miRNA regulons, are currently being expanded to include various modulators of the tumor microenvironment. Recent advances have highlighted two important roles played by miRNAs in the evolution of tumor microenvironments: miRNAs in tumor cells transform the microenvironment via non-cell-autonomous mechanisms, and miRNAs in neighboring cells stabilize cancer hallmark traits. These observations epitomize the distal and proximal functions of miRNAs in tumor microenvironments, respectively. Such regulation by miRNAs affects tumor angiogenesis, immune invasion and tumor-stromal interactions. This review summarizes recent findings on the mechanisms of miRNA-mediated regulation of tumor microenvironments, with a perspective on the design of therapeutic interventions.

Citing Articles

Epigenetic regulation of angiogenesis and its therapeutics.

Choi D Genomics Inform. 2025; 23(1):4.

PMID: 39934895 PMC: 11817428. DOI: 10.1186/s44342-025-00038-3.


Dual Roles of miR-10a-5p and miR-10b-5p as Tumor Suppressors and Oncogenes in Diverse Cancers.

Singh R, Ha S, Yu T, Ro S Int J Mol Sci. 2025; 26(1.

PMID: 39796267 PMC: 11720153. DOI: 10.3390/ijms26010415.


Dysregulated miRNA Expression and Androgen Receptor Loss in Racially Distinct Triple-Negative Breast Cancer.

Bhattarai S, Sugita B, Nunes-Souza E, Fonseca A, Chandrashekar D, Bhargava M Int J Mol Sci. 2025; 25(24).

PMID: 39769441 PMC: 11679545. DOI: 10.3390/ijms252413679.


Combining antimiR-25 and cGAMP Nanocomplexes Enhances Immune Responses via M2 Macrophage Reprogramming.

Petrovic M, Majchrzak O, Marecar R, Laingoniaina A, Walker P, Borchard G Int J Mol Sci. 2024; 25(23).

PMID: 39684497 PMC: 11641323. DOI: 10.3390/ijms252312787.


Investigating miR-9 and miR-222 in CSF and Plasma of Neuroblastoma Patients as Metastatic and Apoptotic-Related Markers.

Bordbar F, Rigi A, Mastanabad M, Rohani F, Ghaedi E, Dhiaa S Cell Biochem Biophys. 2024; .

PMID: 39663279 DOI: 10.1007/s12013-024-01570-9.


References
1.
Bronisz A, Godlewski J, Wallace J, Merchant A, Nowicki M, Mathsyaraja H . Reprogramming of the tumour microenvironment by stromal PTEN-regulated miR-320. Nat Cell Biol. 2011; 14(2):159-67. PMC: 3271169. DOI: 10.1038/ncb2396. View

2.
Sempere L . Integrating contextual miRNA and protein signatures for diagnostic and treatment decisions in cancer. Expert Rev Mol Diagn. 2011; 11(8):813-27. PMC: 3220160. DOI: 10.1586/erm.11.69. View

3.
Chou J, Lin J, Brenot A, Kim J, Provot S, Werb Z . GATA3 suppresses metastasis and modulates the tumour microenvironment by regulating microRNA-29b expression. Nat Cell Biol. 2013; 15(2):201-13. PMC: 3660859. DOI: 10.1038/ncb2672. View

4.
van Hamburg J, Mus A, de Bruijn M, de Vogel L, Boon L, Cornelissen F . GATA-3 protects against severe joint inflammation and bone erosion and reduces differentiation of Th17 cells during experimental arthritis. Arthritis Rheum. 2009; 60(3):750-9. DOI: 10.1002/art.24329. View

5.
Matsuyama H, Suzuki H, Nishimori H, Noguchi M, Yao T, Komatsu N . miR-135b mediates NPM-ALK-driven oncogenicity and renders IL-17-producing immunophenotype to anaplastic large cell lymphoma. Blood. 2011; 118(26):6881-92. DOI: 10.1182/blood-2011-05-354654. View